Home › Leverkanker (hepatocellulair carcinoom) › Texas › San Antonio
Leverkanker (hepatocellulair carcinoom) klinische studies in San Antonio, TX
13 studies voor Leverkanker (hepatocellulair carcinoom) zoeken deelnemers op locaties in en rond San Antonio (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekruterenFase 1
- START San Antonio, San Antonio
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RekruterenFase 3
- Research Site, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekruterenFase 1
- START San Antonio, San Antonio
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RekruterenFase 1
- START-San Antonio, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
RekruterenFase 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruterenFase 1
- Clinical Trial Site, San Antonio
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RekruterenFase 1/2
- University of Texas Health Science Center - San Antonio, San Antonio
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
RekruterenObservatieonderzoek
- Mays Cancer Center, San Antonio
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
RekruterenFase 2
- UT Health San Antonio, San Antonio
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
RekruterenFase 2
- Mays Cancer Center, UT Health San Antonio, San Antonio
Leverkanker (hepatocellulair carcinoom) studies in andere steden
- Houston, TX31 studies
- New York City, NY24 studies
- Dallas, TX19 studies
- Los Angeles, CA19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Chicago, IL16 studies
- Philadelphia, PA16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
Andere studies in San Antonio
- Niet-kleincellige longkanker59 studies
- Borstkanker47 studies
- Colorectale kanker46 studies
- Metastatische kanker44 studies
- Kanker (alle vormen)41 studies
- Obesitas40 studies
- Type 2-diabetes37 studies
- Overgewicht34 studies
- Eierstokkanker31 studies
- Aldermeesklierkanker31 studies
- Prostaatkanker28 studies
- Endometriumkanker27 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.